Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Polyacrylamide Companies

ID: MRFR/CnM/6438-CR
140 Pages
Priya Nagrale
Last Updated: February 16, 2025
Polyacrylamide companies create this versatile polymer, used in various industries, including water treatment, agriculture, and cosmetics.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Polyacrylamide Market

Market Size

Forecast Period2026-2035
CAGR (2026-2035)6.2%
2025 Market SizeUSD 5,480 Million
2035 Market SizeUSD 10,010 Million

Key Players

SNF Group
Kemira Oyj
BASF SE
Solenis LLC
Anhui Jucheng Fine Chemicals
Beijing Hengju Chemical Group
Opportunities
  • Semiconductor-Grade Ultra-Pure Formulations
  • Bio-Grafted Polymer Derivatives
  • Closed-Loop Dosing and Digital Chemical Management

Top Industry Leaders in the Polyacrylamide Market

Polyacrylamide Key Companies

May 2023

Contura Vet USA, the veterinary division of Contura International LTD, and Butterfly Network, Inc. (NYSE: BFLY), a digital health company that is revolutionizing healthcare with handheld, whole-body ultrasound, today announced a strategic partnership to advance the understanding, diagnosis, and treatment of equine osteoarthritis.

ArthramidVet, an injectable 2.5% polyacrylamide hydrogel (iPAAG) and the world's only single probe, whole-body multi-species imaging system, Butterfly iQ+ Vet, used in the management of non-infectious joint lameness in animals, will collaborate to offer a solutions-based educational opportunity.

With the aid of cutting-edge ultrasound technology that has been simplified by artificial intelligence, Butterfly iQ+ Vet provides veterinarians with invaluable clinical insights right at the point of care. A unique iPAAG called ArthramidVet is used to treat all stages of horse osteoarthritis.

Using their facilities in Denmark as a base, Contura International (the parent business of Contura Vet USA) has led the development of polyacrylamide hydrogel technology for both human and veterinary medicine.

August 2023

Polaris Chemicals, Inc., a company formed between Mitsui Chemicals and Kasano Kosan Corporation in 2021, was announced by Mitsui Chemicals, Inc. (Tokyo) to have started producing the biocatalysts needed to produce acrylamide. Acrylamide is a component of polyacrylamide, which is used, among other things, as a strengthening agent for paper, a flocculant for wastewater treatment, and a crude oil recovery agent. Mitsui Chemicals' acrylamide manufacturing biocatalysts have established a solid reputation among acrylamide manufacturers worldwide thanks to the continually increasing demand for acrylamide, which has boosted sales and necessitated expanding production capacity.

Key Companies in the Polyacrylamide market includes

  • BASF SE (Germany)
  • SNF Group (France)
  • China National Petroleum Corporation (China)
  • The Dow Chemical Company (US)
  • PetroChina Company Limited (China)
  • Black Rose Industries Ltdย (India)
  • Xitao Polymer Co., Ltd (China)
  • Kemira OYJย (Finland)
  • ZL Petrochemical Co., Ltd (US)
  • Anhui Jucheng Fine Chemicals Co., Ltd (China).among others